Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links
Cat.#: ACPP-1437
| Despition | LINGO1 Human Recombinant |
| SIZE | 5 µg |
| Purity | > 90.0% (SDS-PAGE) |
| Form | Sterile Filtered colorless solution. |
| Storage | Store at 4°C for 2-4 weeks. |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1016 | Synthetic Nanodisc Human GnRHR Protein (AC1016) | 10 µg | inquiry |
| ACPP-1074 | Myocilin Blocking Peptide (AC1074) | 250 µg | inquiry |
| ACPP-1277 | TSH beta Blocking Peptide (AC1277) | 250 µg | inquiry |
| ACPP-1443 | Human BSND Protein (AC1443) | 2 µg | inquiry |
| ACPP-1706 | Human HPCAL1 Protein (AC1706) | 2 µg | inquiry |
| ACPP-1549 | Human VEGF C Protein (AC1549) | 2 µg | inquiry |
| ACPP-1604 | Human GSK3B Protein (AC1604) | 2 µg | inquiry |
| ACPP-1799 | Human SNAP23 Protein (AC1799) | 5 µg | inquiry |
| ACPP-1392 | Human Dopa Decarboxylase Protein (AC1392) | 5 µg | inquiry |
| ACPP-1318 | Orexin A Blocking Peptide (AC1318) | 250 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.